Public perceptions of cardiovascular risk in five European countries: The react survey

International Journal of Clinical Practice

Volumn 56, Issue 9, 2002, Pages 638-644

  Erhardt, L ^a   Hobbs, F D R ^b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; AWARENESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; EUROPE; FEMALE; FRANCE; GERMANY; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERVIEW; ISCHEMIC HEART DISEASE; ITALY; MALE; MEDICAL INFORMATION; PATIENT ATTITUDE; PHYSICIAN; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTOR; SWEDEN; UNITED KINGDOM;

ADULT; AGED; CORONARY DISEASE; EUROPE; FEMALE; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH SURVEYS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; PERCEPTION; PUBLIC HEALTH; RISK FACTORS; SELF CONCEPT;

EID: 0036855396     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. The World Health Report 1999: making a difference. Report of the Director General. Geneva: World Health Organisation, 1999.
2. Wood D, De Backer G, Faergeman O et al, together with members of the Task Force. Prevention of coronary heart disease in clinical practice: recommendations of the second joint task force of European and other societies on coronary prevention. Eur Heart J 1998; 19: 1434-1503.
3. Kannel WB. Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure. Cardiovasc Drugs Ther 1997; 11: 199-212.
4. Erhardt LR. The essence of effective treatment and compliance is simplicity. Am J Hypertens 1999; 12: 105S-110S.
5. Ebrahim S, Davey Smith G. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. BMJ 1997; 314: 1666.
6. COMMIT Research Group. Community intervention trial for smoking cessation (COMMIT). I. Cohort results from a four year community intervention. Am J Public Health 1995; 85: 183-92.
7. COMMIT Research Group. Community intervention trial for smoking cessation (COMMIT). II. Changes in adult smoking prevalence. Am J Public Health 1995; 85: 193-200.
8. Furnham A. Overcoming the obstacles: the outsider's view. Atherosclerosis 1999; 147(suppl 1): S53-S56.
9. Marteau TM, Kinmonth AL, Pyke S, Thompson SG. Readiness for lifestyle advice: self assessments of coronary risk prior to screening in the British Family Heart Study. Family Heart Study Group. Br J Gen Pract 1995; 45: 3905-3908.
10. Robson J, Boomla K, Hart B, Feder G. Estimating cardiovascular risk for primary prevention: outstanding questions for primary care. BMJ 2000; 320: 702-704.
11. British Heart Foundation. Coronary heart disease statistics, 1999 edn. British Heart Foundation Statistics Database.
12. EUROASPIRE Study Group. EUROASPIRE: a European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J 1997; 18: 1569-1582.
13. EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001; 357: 995-1001.
14. Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP). Arch Intern Med 2000; 160: 459-467.
15. Shepherd J, Pratt M. Prevention of coronary heart disease in clinical practice: a commentary on current treatment patterns in six European countries in relation to published recommendations. Cardiology 1996; 87: 1-5.
16. Berg JS, Dischler J, Wagner DJ. Medication compliance: a health care problem. Ann Pharmacother 1993; 27(suppl): S2-S22.
17. McGovern PG, Arnett DK, Shahar E, Luepker RV. Trends in serum cholesterol levels, 1980-1997: the Minnesota Heart Survey. Circulation 1999; 99: 1104.
18. Primatest P, Poulter NR. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey. BMJ 2000; 321: 1322-1325.
19. Shepherd J, Alcalde V, Béfort P-A et al, the HELP Study Group. International comparison of awareness and attitudes towards coronary risk factor reduction: the HELP study. J Cardiovasc Risk 1997; 4: 373-384.